TARS- Tarsus Pharmaceuticals, Inc.

Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.

TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Azamian Bobak R.	828.0K	$75.57M	-
Dir	Link William J Phd	95.3K	$7.47M	-
COO	Neervannan Seshadri	78.5K	$6.68M	-
Other	Wahl Bryan	64.0K	$4.29M	-
Other	Mottiwala Aziz	61.5K	$4.12M	-

Buys and sells only

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 20, 2023	Greenstein Leonard M.	Chief Financial Officer	Sell	649	$12.94	$8,395.61	-1.9%	+46.1%	+141.5%
Mar 20, 2023	Holdbrook Mark J.	V.p., Clinical Affairs	Sell	386	$12.94	$4,993.42	-10.8%	+46.1%	+141.5%
Mar 20, 2023	Neervannan Seshadri	Chief Operating Officer	Sell	740	$12.94	$9,572.60	-1.3%	+46.1%	+141.5%
Mar 20, 2023	Azamian Bobak R.45	President/ CEO And Board Chair	Sell	1,536	$12.96	$19,901.61	-12.5%	+46.1%	+141.5%
Mar 20, 2023	Whitfield Dianne C.	Chief Human Resources Officer	Sell	649	$12.94	$8,395.61	-5.0%	+46.1%	+141.5%
Mar 20, 2023	Wahl Bryan	General Counsel	Sell	696	$12.94	$9,003.69	-3.8%	+46.1%	+141.5%
Mar 16, 2023	Greenstein Leonard M.	Chief Financial Officer	Sale+OE	5,313	$13.44	$71,403.59	-13.7%	+38.5%	+135.3%
Mar 16, 2023	Azamian Bobak R.45	President/ CEO And Board Chair	Sale+OE	8,791	$13.76	$120,943.13	-41.8%	+38.5%	+135.3%
Mar 16, 2023	Neervannan Seshadri	Chief Operating Officer	Sale+OE	357	$13.43	$4,794.51	-0.6%	+38.5%	+135.3%
Mar 16, 2023	Mottiwala Aziz51	Chief Commercial Officer	Sale+OE	336	$13.43	$4,512.48	-0.6%	+38.5%	+135.3%